Mitochondrion
The mitochondrion (plural: mitochondria) is a double-membrane-bound organelle found in the cytoplasm of virtually all eukaryotic cells, widely recognized as the primary site of cellular energy production.
The mitochondrion (plural: mitochondria) is a double-membrane-bound organelle found in the cytoplasm of virtually all eukaryotic cells, widely recognized as the primary site of cellular energy production. Through the process of oxidative phosphorylation (OXPHOS), mitochondria convert nutrients into adenosine triphosphate (ATP), the universal energy currency of the cell. Beyond energy metabolism, mitochondria serve as central regulators of redox homeostasis, calcium signaling, programmed cell death (apoptosis), and cellular senescence. Their outer membrane contains specialized transmembrane β-barrel proteins that function as molecular gatekeepers, a structural feature shared with the outer membranes of Gram-negative bacteria and chloroplasts — a reflection of their endosymbiotic evolutionary origin. Critically, mitochondria harbor their own genome (mitochondrial DNA, or mtDNA), a circular chromosome encoding essential components of the respiratory chain, which is maintained under strict nuclear control and exists in multiple copies per cell, giving rise to phenomena such as heteroplasmy.
Mitochondria are now understood to be far more than static powerhouses. They form dynamic networks that undergo continuous fusion and fission, communicate with other organelles including the endoplasmic reticulum and lysosomes, and can even transfer between cells via tunneling nanotubes, extracellular vesicles, and as free organelles. Disruption of these functions — through oxidative stress, epigenetic dysregulation, impaired mitophagy, or mtDNA mutation — underlies a broad spectrum of human disease, including cardiovascular disease, neurodegeneration, cancer, chronic renal insufficiency, and age-related disorders. This central pathophysiological role has made mitochondria one of the most intensively studied targets in modern biomedical research and drug delivery science.
Where the papers sit
18 papers from the last 6 months study mitochondrion directly · updated from PubMed 15 Nov 2026
Study type 0 clinical trials · 1 human data · 15 preclinical · 2 unclassified
Themes 4 themes · 2 new directions
-
Mitochondrial ROS and Cell Death
Mitochondrial ROS is being exploited to trigger pyroptosis and immunogenic cancer-cell death, while antioxidant strategies target redox injury in sepsis. Mitochondria-targeted photosensitizers, probes and nanoparticles recur as tools for generating localized oxidative stress. β-elemene is linked to mitochondrial metabolic reprogramming and Drp1-dependent fission, with additional effects in colitis inflammation and cervical cancer. The shared focus is redox-controlled cell fate, spanning therapeutic induction and protection.
8 papers · 44.4%
-
Mitochondrial Homeostasis in Disease
Mitochondrial fitness is being treated as a determinant of tissue repair, immune function, cancer outcome and vascular calcification. Hydrogels aim to preserve mitochondrial function in diabetic wounds and exhausted CD8+ T cells. In colon cancer, mitochondrial metabolism and succinylation signatures are being tested for prognosis and drug-resistance prediction. Complex I inhibition with rotenone offers a contrasting strategy for reducing arterial calcification, leaving the best direction context-dependent.
4 papers · 22.2%
-
Mitochondrial-Targeted Therapeutics
Therapeutic design is shifting toward directing diverse agents to mitochondria rather than treating them as nonspecific targets. Ruthenium complexes are engineered to induce mitochondria-mediated apoptosis in melanoma, while semaglutide is studied for restoring muscle mitochondrial glutamine metabolism in osteoarthritis. Nanodiamond systems extend this approach to delivery of bioactive peptides. The applications differ, but localization, selective mitochondrial engagement and tissue-specific benefit recur throughout.
3 papers · 16.7%
-
Mitochondria in Neurodegeneration
Neurodegenerative disease research is linking tau and alpha-synuclein pathology to disrupted mitochondrial quality control and trafficking. Donepezil-loaded nanosystems aim to activate mitophagy while reshaping inflammatory signaling in Alzheimer's disease. Tau is framed as a disruptor of neuronal energy production, whereas alpha-synuclein fibrils induce mitochondrial-derived vesicle budding. The field is moving toward restoring mitochondrial clearance and communication alongside conventional symptom-directed treatment.
3 papers · 16.7%
Frailty is framed as mitochondrial energetic congestion rather than primary bioenergetic failure
Frailty in aging, particularly sarcopenic obesity, is presented against the assumed model of primary mitochondrial bioenergetic insufficiency; instead, the mitochondrion is characterized as an organelle constrained by a chronic mismatch between substrate input, energetic demand, and the capacity to dispatch metabolic flux through demand-driven oxidation. This shifts the proposed therapeutic focus from simply restoring mitochondrial energy production to improving mitochondrial adaptability and systemic metabolic handling 42472600Jul.
Alpha-synuclein fibrils implicate mitochondria as active producers of trafficking vesicles
Alpha-synuclein fibrils in SH-SY5Y cells are shown not only to damage mitochondrial cristae, as would be expected from a dysfunction-centered account, but also to stimulate budding of mitochondrial-derived vesicles and alter proteins governing their formation and trafficking. This assigns mitochondria an active vesicle-biogenesis and cargo-trafficking role in the cellular response to protein aggregation, extending beyond their use in the set as damaged energy-producing or stress-sensitive organelles 42258734Jun.
Papers
The 18 papers from the last 6 months that study mitochondrion directly, newest first, by theme and by study type. Study types come from PubMed publication types and MeSH headings.
By theme
Mitochondrial ROS and Cell Death (8)
- Mitochondria-targeted tertiary amine N-Oxide nanoparticles with photosensitizer conjugation for photopyroptotic cancer therapy. Biomedical materials (Bristol, England) · 16 Oct 2026 PMID 42887531
- Evaluation of curcumin as an exploratory pharmacological tool for modulating dysregulated molecular pathways in cellular models of Huntington's disease. Molecular biology reports · 9 Sept 2026 PMID 42714706
- β-Elemene Triggers Drp1-Dependent Mitochondrial Fission Through CDK1/Cyclin B1 Signaling in Cervical Cancer Cells. Journal of biochemical and molecular toxicology · 27 Jul 2026 PMID 42506883
- A Mitochondria-Targeted Iridium(III) Complex as a Potent Type-I/II Photosensitizer for Pyroptosis-Based Breast Cancer Therapy. Journal of medicinal chemistry · 23 Jul 2026 PMID 42489638
- Rethinking frailty as a disorder of mitochondrial adaptability, from energetic congestion to systemic vulnerability. Pharmacological research · 19 Jul 2026 PMID 42472600
- ROS-Triggered Self-Aggregation of a β-Elemene Olefin-Rich Nanoemulsion for Mitochondrial-Targeted Metabolic Reprogramming and Colitis Inflammation Alleviation. International journal of nanomedicine · 15 Jun 2026 PMID 42292035
- Autophagy-ferroptosis crosstalk in sepsis: metabolic pathways, redox injury, and host-directed antioxidant nanomedicine. Frontiers in immunology · 12 Jun 2026 PMID 42282965
- In Situ Activating a Protein-Complexed Quenched Probe via Alkaline Phosphatase Response for Pyroptosis-Mediated Cancer Immunotherapy. Angewandte Chemie (International ed. in English) · 4 Jun 2026 PMID 42241249
Mitochondrial Homeostasis in Disease (4)
- An in situ forming immunomodulatory hydrogel reinvigorates exhausted CD8+ T cells via preserving their mitochondrial fitness. Science advances · 23 Oct 2026 PMID 42913016
- Inhibition of mitochondrial complex I by rotenone reduces arterial calcification in vitro. Biochemical and biophysical research communications · 30 Jul 2026 PMID 42531909
- Bio-recruiting hydrogel targeting mitochondrial homeostasis under neutrophil extracellular traps for diabetic wound repair. Journal of controlled release : official journal of the Controlled Release Society · 30 Jun 2026 PMID 42379309
- Mitochondrial metabolism and succinylation-related gene signatures for predicting prognosis and drug resistance in colon adenocarcinoma. Clinica chimica acta; international journal of clinical chemistry · 23 May 2026 PMID 42176930
Mitochondrial-Targeted Therapeutics (3)
- Fluorescent Nanodiamond-Based Delivery Systems for Mitochondrial Targeting of Bioactive Peptides. ACS applied bio materials · 1 Sept 2026 PMID 42675618
- Architectural Tuning of Ruthenium Centers to Drive Mitochondria-Mediated Apoptosis in Melanoma Cells. ACS biomaterials science & engineering · 20 Aug 2026 PMID 42623588
- Semaglutide targets muscle mitochondria to regulate glutamine metabolism and treat osteoarthritis. iScience · 17 Jun 2026 PMID 42305583
Mitochondria in Neurodegeneration (3)
- Tau can wreak havoc in brain cells' energy factories. Science (New York, N.Y.) · 13 Aug 2026 PMID 42594210
- A Multitarget Nanosystem Loaded with Donepezil for Alzheimer's Disease Treatment by Activating Mitophagy and Reshaping the Inflammatory Microenvironment. ACS applied materials & interfaces · 13 Jul 2026 PMID 42441421
- Alpha-synuclein fibrils induce budding of mitochondrial-derived vesicles. Proceedings of the National Academy of Sciences of the United States of America · 8 Jun 2026 PMID 42258734
By study type
Human data, design not indexed (1)
- Mitochondrial metabolism and succinylation-related gene signatures for predicting prognosis and drug resistance in colon adenocarcinoma. Clinica chimica acta; international journal of clinical chemistry · 23 May 2026 PMID 42176930
Preclinical: animal, cell and lab studies (15)
- An in situ forming immunomodulatory hydrogel reinvigorates exhausted CD8+ T cells via preserving their mitochondrial fitness. Science advances · 23 Oct 2026 PMID 42913016
- Mitochondria-targeted tertiary amine N-Oxide nanoparticles with photosensitizer conjugation for photopyroptotic cancer therapy. Biomedical materials (Bristol, England) · 16 Oct 2026 PMID 42887531
- Evaluation of curcumin as an exploratory pharmacological tool for modulating dysregulated molecular pathways in cellular models of Huntington's disease. Molecular biology reports · 9 Sept 2026 PMID 42714706
- Fluorescent Nanodiamond-Based Delivery Systems for Mitochondrial Targeting of Bioactive Peptides. ACS applied bio materials · 1 Sept 2026 PMID 42675618
- Architectural Tuning of Ruthenium Centers to Drive Mitochondria-Mediated Apoptosis in Melanoma Cells. ACS biomaterials science & engineering · 20 Aug 2026 PMID 42623588
- Tau can wreak havoc in brain cells' energy factories. Science (New York, N.Y.) · 13 Aug 2026 PMID 42594210
- Inhibition of mitochondrial complex I by rotenone reduces arterial calcification in vitro. Biochemical and biophysical research communications · 30 Jul 2026 PMID 42531909
- β-Elemene Triggers Drp1-Dependent Mitochondrial Fission Through CDK1/Cyclin B1 Signaling in Cervical Cancer Cells. Journal of biochemical and molecular toxicology · 27 Jul 2026 PMID 42506883
- A Mitochondria-Targeted Iridium(III) Complex as a Potent Type-I/II Photosensitizer for Pyroptosis-Based Breast Cancer Therapy. Journal of medicinal chemistry · 23 Jul 2026 PMID 42489638
- A Multitarget Nanosystem Loaded with Donepezil for Alzheimer's Disease Treatment by Activating Mitophagy and Reshaping the Inflammatory Microenvironment. ACS applied materials & interfaces · 13 Jul 2026 PMID 42441421
- Bio-recruiting hydrogel targeting mitochondrial homeostasis under neutrophil extracellular traps for diabetic wound repair. Journal of controlled release : official journal of the Controlled Release Society · 30 Jun 2026 PMID 42379309
- ROS-Triggered Self-Aggregation of a β-Elemene Olefin-Rich Nanoemulsion for Mitochondrial-Targeted Metabolic Reprogramming and Colitis Inflammation Alleviation. International journal of nanomedicine · 15 Jun 2026 PMID 42292035
- Autophagy-ferroptosis crosstalk in sepsis: metabolic pathways, redox injury, and host-directed antioxidant nanomedicine. Frontiers in immunology · 12 Jun 2026 PMID 42282965
- Alpha-synuclein fibrils induce budding of mitochondrial-derived vesicles. Proceedings of the National Academy of Sciences of the United States of America · 8 Jun 2026 PMID 42258734
- In Situ Activating a Protein-Complexed Quenched Probe via Alkaline Phosphatase Response for Pyroptosis-Mediated Cancer Immunotherapy. Angewandte Chemie (International ed. in English) · 4 Jun 2026 PMID 42241249
Unclassified: not yet indexed with MeSH (2)
- Rethinking frailty as a disorder of mitochondrial adaptability, from energetic congestion to systemic vulnerability. Pharmacological research · 19 Jul 2026 PMID 42472600
- Semaglutide targets muscle mitochondria to regulate glutamine metabolism and treat osteoarthritis. iScience · 17 Jun 2026 PMID 42305583
Written from 18 PubMed abstracts, each one listed by PMID above. Published: 2026-06-14. Last written: 2026-09-11 by GPT. Drafted by language models from published abstracts; not medical advice.